Solanezumab: Late-Stage Trial Of Alzheimer's Drug Planned After Prior Failures (WELLNESS)
By Ransdell Pierson July 12 (Reuters) - Despite two failed late-stage trials of its experimental Alzheimer's drug solanezumab